Trastuzumab plus paclitaxel in HER-2 positive metastatic breast cancer: A single institutional experience

被引：0
|
作者：
Capobianco, A. M. L. [1 ]
Di Leo, P. [1 ]
Bochicchio, A. M. [1 ]
Coccaro, M. [1 ]
Romano, G. [1 ]
Tartarone, A. [1 ]
Ardito, R. [1 ]
Musto, C. [1 ]
Barone, M. [1 ]
Guarigli, R. [1 ]
Di Renzo, N. [1 ]
机构：
[1] Reg Hosp, Ctr Riferimento Oncol Basilicata, Div Hematol Oncol, Rionero In Vulture, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [21] PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study
    Pegram, Mark D.
    Bondarenko, Igor
    Costa Zorzetto, Marina Moreira
    Hingmire, Sachin
    Iwase, Hirotaka
    Krivorotko, Petr V.
    Lee, Keun Seok
    Li, Rubi K.
    Pikiel, Joanna
    Aggarwal, Rajesh
    Ewesuedo, Reginald
    Freyman, Amy
    Li, Ray
    Vana, Alicia
    Yin, Donghua
    Zacharchuk, Charles
    Tan-Chiu, Elizabeth
    BRITISH JOURNAL OF CANCER, 2019, 120 (02) : 172 - 182
  • [22] PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study
    Mark D. Pegram
    Igor Bondarenko
    Marina Moreira Costa Zorzetto
    Sachin Hingmire
    Hirotaka Iwase
    Petr V. Krivorotko
    Keun Seok Lee
    Rubi K. Li
    Joanna Pikiel
    Rajesh Aggarwal
    Reginald Ewesuedo
    Amy Freyman
    Ray Li
    Alicia Vana
    Donghua Yin
    Charles Zacharchuk
    Elizabeth Tan-Chiu
    British Journal of Cancer, 2019, 120 : 172 - 182
  • [23] HER-2 positive breast cancer and trastuzumab: lessons learnt by heart
    Outhoff, k
    SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 1 (02) : 52 - 57
  • [24] Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer
    Tonyali, Onder
    Benekli, Mustafa
    Berk, Veli
    Coskun, Ugur
    Ozkan, Metin
    Yildiz, Ramazan
    Ucgul, Emel
    Sevinc, Alper
    Uncu, Dogan
    Demirci, Umut
    Buyukberber, Suleyman
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (06) : 981 - 986
  • [25] Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer
    Onder Tonyali
    Mustafa Benekli
    Veli Berk
    Ugur Coskun
    Metin Ozkan
    Ramazan Yildiz
    Emel Ucgul
    Alper Sevinc
    Dogan Uncu
    Umut Demirci
    Suleyman Buyukberber
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 981 - 986
  • [26] Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy
    Nunes, Raquel A.
    Li, Xiaochun
    Kang, Soonmo Peter
    Burstein, Harold
    Roberts, Lisa
    Carney, Walter
    Blackwell, Kimberly
    Ryan, Paula
    Borges, Virginia
    Iglehart, J. Dirk
    Friedman, Paula
    Harris, Lyndsay N.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (01): : 1 - 10
  • [27] High pathologic complete remission rate with liposome-encapsulated doxorubicin plus paclitaxel plus trastuzumab as primary treatment in HER-2 positive operable breast cancer: clinical experience
    Gavila, J.
    Guerrero-Zotano, A.
    Climent, M. A.
    Blanch, S.
    Guillem, V.
    Camp, J.
    Tortajada, M. I.
    Gozalbo, F.
    Vidal, P.
    Ruiz, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 68 - 69
  • [28] Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer
    Ardavanis, Alexandros
    Kountourakis, Panteleimon
    Kyriakou, Flora
    Malliou, Savoula
    Mantzaris, Ioannis
    Garoufali, Anastasia
    Yiotis, Ioulia
    Scorilas, Andreas
    Baziotis, Nikolaos
    Rigatos, Gerasimos
    ONCOLOGIST, 2008, 13 (04): : 361 - 369
  • [29] Efficacy and tolerability of neoadjuvant Pertuzumab, Trastuzumab, and weekly Paclitaxel in Locally advanced Her-2 positive Breast cancer
    Gupta, Niraj
    Giblin, Erica
    Spivey, Tara
    Govert, Kristen
    Leagre, Christopher
    Liebross, Robert
    Tumati, Vasu
    Dugan, Thomas
    Yadav, Rina
    Henman, Patrick
    Beaudrie, Nick
    Bair, Tessa
    Durk, Jessica
    Hancock, Marjaorie
    Engle, Trisha
    Myers, Michelle
    Schneiders, Julie
    Tigges, Thomas
    CANCER RESEARCH, 2021, 81 (04)
  • [30] Complete response after docetaxel plus pertuzumab plus trastuzumab chemotherapy for multimetastatic positive Her-2 breast cancer
    Lai-Tiong, F.
    Van-Hulst, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (04) : 662 - 664
12345